Novartis Archives

Metabolic News Weekly: June 11, 2024

Diabetes and Metabolic Dysfunction–Associated Steatotic Liver Disease June 10, 2024 / Type 2 Diabetes / MASLD / Insulin Resistance/ Obesity-related Liver Disease Type 2 diabetes and metabolic dysfunction-associated steatotic liver disease (MASLD) share risk factors like obesity and insulin resistance....

June 11, 2024

Metabolic News Weekly

Metabolic News Weekly: June 4, 2024

Two diabetes medications more beneficial in preventing major cardiovascular events June 3, 2024 / GLP-1 / Diabetes / Heart Protection / Liver Complications GLP-1 receptor agonists and SGLT-2 inhibitors reduce major cardiovascular events and severe liver complications in type 2...

June 4, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: May 23, 2024

// Biotech and Pharma Therapeutics Regeneron faces new biosimilar threats; an AI biotech lays off staff May 22, 2024 / Regeneron Biosimilars / Boehringer Ingelheim / OSE Deal / GSK Regeneron faces new competition from FDA-approved biosimilars for Eylea. Boehringer...

May 23, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: May 16, 2024

// Biotech and Pharma Therapeutics AstraZeneca withdraws COVID-19 vaccine, citing declining demand May 14, 2024 / AbbVie / Drug Development / Neuroplasticity / Psychedelic Medicine / Mental HealthAbbVie partners with Gilgamesh Pharmaceuticals to expand its psychiatric drug pipeline, focusing on...

May 16, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: May 9, 2024

// Biotech and Pharma Therapeutics AstraZeneca withdraws COVID-19 vaccine, citing declining demand May 8, 2024 / AstraZeneca / Covid-19 / Vaccine Like other companies that successfully developed a coronavirus shot during the pandemic, AstraZeneca is grappling with a seismic shift...

May 9, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: May 2, 2024

// Biotech and Pharma Therapeutics FTC targets ‘junk patents’ on Ozempic, other top drugs May 1, 2024 / Ozempic / FDA / Drug Pricing / FDA The FTC is targeting over 300 patents associated with top-selling drugs like Ozempic, aiming...

May 2, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: April 25, 2024

// Biotech and Pharma Therapeutics Bristol Myers taps startup to boost cell therapy production April 22, 2024 / Cell Therapy / CAR-T Therapies / Bristol Myers Squibb / Partnership Bristol Myers Squibb has partnered with Cellares, a California-based startup, to...

April 25, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: April 18, 2024

// Biotech and Pharma Therapeutics Lilly obesity drug shows benefit in sleep disorder study, pointing to new use April 17, 2024 / Eli Lilly / Obesity / Sleep Disorder / GLP-1 / Clinical Trials Fresh clinical trial results for Eli...

April 18, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: April 11, 2024

// Biotech and Pharma Therapeutics AACR 2024: Getting older younger may be driving rise in early-onset cancers April 8, 2024 / Cancer / AACR As with most common diseases of the developed world, aging is the major risk factor for...

April 11, 2024

Weekly Wrap-Up

Healthcare Industry News Weekly Wrap-Up: February 22, 2024

// Biotech and Pharma Therapeutics Phage therapy: Researchers sharpen another arrow in the quiver against antibiotic resistance February 20, 2024 / Antibiotic Resistance / New Drug “It just got so frustrating over the years because we couldn’t find the source,...

February 22, 2024

1 2 … 4 5

Tag: Novartis